rugs Controller General of India

DCGI approves Phase 2, 3 clinical trials of COVAXIN on children aged 2 to 18 years

The Drugs Controller General of India (DCGI) on Thursday approved Phase 2 and 3 clinical trial of Bharat Biotech's COVAXIN vaccine in the age group of...

Thursday, May 13, 2021 12:18 PM